Variable | Missing data | Median (interquartile range)a | SFCs to ESAT-6 | SFCs to CFP-10 | |||
---|---|---|---|---|---|---|---|
N | (%) | SRCC | P value | SRCC | P value | ||
Age, years | 0 | (00.0) | 53.0 (36.0–66.0) | − 0.102 | 0.054 | − 0.107b | 0.042 |
Body mass index, kg/m2 | 6 | (1.7) | 19.1 (17.6–21.2) | 0.030 | 0.565 | 0.013 | 0.801 |
Duration of symptoms, days | 0 | (00.0) | 90.0 (30.0–496.3) | − 0.073 | 0.165 | 0.025 | 0.630 |
Hemoglobin, g/L | 0 | (00.0) | 118.0 (105.0–134.8) | 0.034 | 0.518 | 0.016 | 0.765 |
Platelet, ×109/L, | 0 | (00.0) | 258.0 (191.0–320.8) | 0.173c | 0.001 | 0.186c | <0.001 |
Platelet distribution width, fL | 0 | (00.0) | 14.0 (11.7–16.2) | −0.090 | 0.089 | −0.116b | 0.027 |
Erythrocyte sedimentation rate, mm/H | 32 | (8.9) | 49.9 (28.3–69.0) | −0.070 | 0.184 | −0.028 | 0.594 |
Prealbumin, mg/L | 39 | (10.8) | 143.6 (84.3–184.8) | 0.187c | <0.001 | 0.104b | 0.050 |
Albumin, g/L | 1 | (0.3) | 31.9 (27.6–36.5) | 0.159c | 0.002 | 0.108b | 0.040 |
Globulin, g/L | 5 | (1.4) | 32.6 (28.9–36.1) | 0.014 | 0.795 | 0.049 | 0.356 |
Albumin-globulin ratio | 5 | (1.4) | 1.0 (0.8–1.2) | 0.105b | 0.047 | 0.054 | 0.303 |
Alpha-1 globulin, g/L | 40 | (11.1) | 4.9 (3.7–5.6) | −0.122b | 0.020 | −0.077 | 0.146 |
Alpha-2 globulin, g/L | 40 | (11.1) | 7.6 (6.5–8.6) | 0.091 | 0.085 | 0.141c | 0.007 |
Beta-1 globulin, g/L | 40 | (11.1) | 3.7 (3.3–4.1) | 0.111b | 0.036 | 0.058 | 0.270 |
Beta-2 globulin, g/L | 40 | (11.1) | 3.7 (3.2–4.1) | 0.034 | 0.514 | 0.063 | 0.233 |
Gamma globulin, g/L | 40 | (11.1) | 13.0 (10.4–14.7) | 0.012 | 0.823 | 0.014 | 0.797 |
CD4+ T lymphocytes, cells/μL | 89 | (24.7) | 302.0 (203.0–445.0) | 0.391c | <0.001 | 0.230c | <0.001 |
CD8+ T lymphocytes, cells/μL | 89 | (24.7) | 253.0 (164.0–379.0) | 0.291c | <0.001 | 0.190c | <0.001 |
CD4+ to CD8+ ratio | 89 | (24.7) | 1.2 (0.9–1.7) | 0.049 | 0.354 | −0.042 | 0.425 |